Analysis of off-label drug use and its influencing factors in pediatric patients undergoing otolaryngology, head, and neck surgery.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1553221
- By:
- Publication type:
- Article
Works matching DE "OFF-label use (Drugs)"
Results: 1713
1
2
基于循证医学方法评价注射用雷替曲塞超适应证 用药情况.
- Published in:
- Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi, 2025, v. 25, n. 5, p. 595, doi. 10.14009/j.issn.1672-2124.2025.05.017
- By:
- Publication type:
- Article
3
Ropivacaine and dexamethasone: Better to separate than mixing together.
- Published in:
- Indian Journal of Anaesthesia, 2025, v. 69, n. 7, p. 733, doi. 10.4103/ija.ija_1269_24
- By:
- Publication type:
- Article
4
3 Things You Should Know About Comanaging TED.
- Published in:
- Optometry Times, 2025, v. 17, n. 3, p. 64
- By:
- Publication type:
- Article
5
3 Things You Should Know About Comanaging Geographic Atrophy.
- Published in:
- Optometry Times, 2025, v. 17, n. 3, p. 61
- By:
- Publication type:
- Article
6
3 Things You Should Know About Interventional Glaucoma Comanagement.
- Published in:
- Optometry Times, 2025, v. 17, n. 3, p. 58
- By:
- Publication type:
- Article
7
3 Things You Should Know About Neurostimulation Techniques for DED Management.
- Published in:
- Optometry Times, 2025, v. 17, n. 3, p. 55
- By:
- Publication type:
- Article
8
Off-label drugs in laryngology– what should the doctor and the patient know about such therapies? A consensus statement of the European Laryngological Society.
- Published in:
- European Archives of Oto-Rhino-Laryngology, 2025, v. 282, n. 6, p. 3133, doi. 10.1007/s00405-025-09406-9
- By:
- Publication type:
- Article
9
Efficacy and Safety of Gabapentinoids in the Treatment of Carpal Tunnel Syndrome: A Systematic Review and Meta-Analysis.
- Published in:
- Journal of Hand Surgery (Asian-Pacific Volume), 2025, v. 30, n. 3, p. 243, doi. 10.1142/S2424835525500328
- By:
- Publication type:
- Article
10
Osilodrostat Safety Profile: Findings from Real-World Data in the FAERS Database.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 10, p. 3518, doi. 10.3390/jcm14103518
- By:
- Publication type:
- Article
11
Oncology Care in 2021: the FDA, Medicare, and Healthcare Reform.
- Published in:
- 2011
- Publication type:
- Interview
12
Radioiodine-Resistant Differentiated Thyroid Cancer: Hope for the Future.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 9, p. 775
- By:
- Publication type:
- Article
13
New Directions in the Systemic Treatment of Metastatic Thyroid Cancer.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 9, p. 768
- By:
- Publication type:
- Article
14
Using price-volume agreements to manage pharmaceutical leakage and off-label promotion.
- Published in:
- European Journal of Health Economics, 2015, v. 16, n. 7, p. 747, doi. 10.1007/s10198-014-0626-0
- By:
- Publication type:
- Article
15
Compulsory licensing and access to drugs.
- Published in:
- European Journal of Health Economics, 2015, v. 16, n. 1, p. 83, doi. 10.1007/s10198-013-0556-2
- By:
- Publication type:
- Article
16
Strategies and Practices in Off-Label Marketing of Pharmaceuticals: A Retrospective Analysis of Whistleblower Complaints.
- Published in:
- PLoS Medicine, 2011, v. 8, n. 4, p. 1, doi. 10.1371/journal.pmed.1000431
- By:
- Publication type:
- Article
17
Informed Consent and Shared Decision-Making: A Requirement to Disclose to Patients Off-Label Prescriptions.
- Published in:
- PLoS Medicine, 2008, v. 5, n. 11, p. e223, doi. 10.1371/journal.pmed.0050223
- By:
- Publication type:
- Article
18
Off-Label Promotion, On-Target Sales.
- Published in:
- PLoS Medicine, 2008, v. 5, n. 10, p. 1432, doi. 10.1371/journal.pmed.0050210
- By:
- Publication type:
- Article
19
Refractory Immune-Mediated Cysticercal Meningitis and Role of B Cell Depleting Therapy.
- Published in:
- Neurology India, 2024, v. 72, n. 3, p. 615, doi. 10.4103/neuroindia.NI_1721_20
- By:
- Publication type:
- Article
20
No Safe Haven for FDA.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
21
Anabolic agents: what is beyond osteoporosis?
- Published in:
- Osteoporosis International, 2018, v. 29, n. 5, p. 1009, doi. 10.1007/s00198-018-4507-8
- By:
- Publication type:
- Article
22
Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis.
- Published in:
- Osteoporosis International, 2017, v. 28, n. 4, p. 1167, doi. 10.1007/s00198-016-3881-3
- By:
- Publication type:
- Article
23
Lethal thyroid storm after uncontrolled intake of liothyronine in order to lose weight.
- Published in:
- 2010
- By:
- Publication type:
- Report
24
Prescribing patterns of glucagon-like peptide-1 receptor agonists in the Swedish capital region—a register-based cross-sectional study.
- Published in:
- European Journal of Clinical Pharmacology, 2025, v. 81, n. 5, p. 739, doi. 10.1007/s00228-025-03823-9
- By:
- Publication type:
- Article
25
Off-label use of dexmedetomidine in paediatric anaesthesiology: an international survey of 791 (paediatric) anaesthesiologists.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 4, p. 625, doi. 10.1007/s00228-020-03028-2
- By:
- Publication type:
- Article
26
Prevalence of medication and off-label medication use in acquired brain injury at a neurorehabilitation hospital.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 7, p. 985, doi. 10.1007/s00228-019-02651-y
- By:
- Publication type:
- Article
27
The evidence-based choice for antipsychotics in children and adolescents should be guaranteed.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 6, p. 769, doi. 10.1007/s00228-019-02641-0
- By:
- Publication type:
- Article
28
Towards preventive pharmacovigilance through medicine misuse identification: an example with recombinant human growth hormone for aesthetic purposes.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 11, p. 1471, doi. 10.1007/s00228-018-2510-9
- By:
- Publication type:
- Article
29
The changing multiple sclerosis treatment landscape: impact of new drugs and treatment recommendations.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 5, p. 663, doi. 10.1007/s00228-018-2429-1
- By:
- Publication type:
- Article
30
The antipsychotic agent quetiapine is increasingly not used as such: dispensed prescriptions in Norway 2004-2015.
- Published in:
- European Journal of Clinical Pharmacology, 2017, v. 73, n. 9, p. 1173, doi. 10.1007/s00228-017-2281-8
- By:
- Publication type:
- Article
31
Off-label use of antimicrobials in neonates in a tertiary children's hospital.
- Published in:
- European Journal of Clinical Pharmacology, 2017, v. 73, n. 5, p. 609, doi. 10.1007/s00228-017-2200-z
- By:
- Publication type:
- Article
32
Evaluation of the pharmacokinetics of glibenclamide tablet given, off label, orally to children suffering from neonatal syndromic hyperglycemia.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 11, p. 1373, doi. 10.1007/s00228-016-2119-9
- By:
- Publication type:
- Article
33
Off-label use of the expensive orphan drug eculizumab in France 2009-2013 and the impact of literature: focus on the transplantation field.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 6, p. 737, doi. 10.1007/s00228-016-2027-z
- By:
- Publication type:
- Article
34
Off-label and unlicensed drug treatments in Neonatal Intensive Care Units: an Italian multicentre study.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 1, p. 117, doi. 10.1007/s00228-015-1962-4
- By:
- Publication type:
- Article
35
It is time to review how unlicensed medicines are used.
- Published in:
- European Journal of Clinical Pharmacology, 2015, v. 71, n. 9, p. 1029, doi. 10.1007/s00228-015-1886-z
- By:
- Publication type:
- Article
36
Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990-2012.
- Published in:
- European Journal of Clinical Pharmacology, 2015, v. 71, n. 9, p. 1129, doi. 10.1007/s00228-015-1895-y
- By:
- Publication type:
- Article
37
Use of off-label and unlicenced drugs in hospitalised paediatric patients: a systematic review.
- Published in:
- European Journal of Clinical Pharmacology, 2015, v. 71, n. 1, p. 1, doi. 10.1007/s00228-014-1768-9
- By:
- Publication type:
- Article
38
Outcomes of off-label drug uses in hospitals: a multicentric prospective study.
- Published in:
- European Journal of Clinical Pharmacology, 2014, v. 70, n. 11, p. 1385, doi. 10.1007/s00228-014-1746-2
- By:
- Publication type:
- Article
39
Strategy to address innovative off-label medication use in China: grading management.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
40
Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort study.
- Published in:
- European Journal of Clinical Pharmacology, 2014, v. 70, n. 6, p. 719, doi. 10.1007/s00228-014-1662-5
- By:
- Publication type:
- Article
41
The impact of legislation on drug substances used off-label in paediatric wards-a nationwide study.
- Published in:
- European Journal of Clinical Pharmacology, 2014, v. 70, n. 4, p. 445, doi. 10.1007/s00228-013-1626-1
- By:
- Publication type:
- Article
42
Available evidence and outcome of off-label use of rituximab in clinical practice.
- Published in:
- European Journal of Clinical Pharmacology, 2013, v. 69, n. 9, p. 1689, doi. 10.1007/s00228-013-1518-4
- By:
- Publication type:
- Article
43
Anti-androgen prescribing patterns, patient treatment adherence and influencing factors; results from the nationwide PCBaSe Sweden.
- Published in:
- European Journal of Clinical Pharmacology, 2012, v. 68, n. 12, p. 1619, doi. 10.1007/s00228-012-1290-x
- By:
- Publication type:
- Article
44
Bevacizumab treatment in hereditary hemorrhagic teleangiectasia.
- Published in:
- 2012
- By:
- Publication type:
- Letter
45
Paediatric adverse drug reactions reported to the Spanish Pharmacovigilance System from 2004 to 2009.
- Published in:
- European Journal of Clinical Pharmacology, 2012, v. 68, n. 9, p. 1329, doi. 10.1007/s00228-012-1255-0
- By:
- Publication type:
- Article
46
Unlicensed and off-label drug use in hospitalized children in Croatia: a cross-sectional survey.
- Published in:
- European Journal of Clinical Pharmacology, 2012, v. 68, n. 7, p. 1073, doi. 10.1007/s00228-012-1221-x
- By:
- Publication type:
- Article
47
Children's views on unlicensed/off-label paediatric prescribing and paediatric clinical trials.
- Published in:
- European Journal of Clinical Pharmacology, 2012, v. 68, n. 2, p. 141, doi. 10.1007/s00228-011-1110-8
- By:
- Publication type:
- Article
48
Off-label and unlicensed medicine use and adverse drug reactions in children: a narrative review of the literature.
- Published in:
- European Journal of Clinical Pharmacology, 2012, v. 68, n. 1, p. 21, doi. 10.1007/s00228-011-1097-1
- By:
- Publication type:
- Article
49
Drug utilisation pattern and off-label use of medicines in Estonian neonatal units.
- Published in:
- European Journal of Clinical Pharmacology, 2011, v. 67, n. 12, p. 1263, doi. 10.1007/s00228-011-1072-x
- By:
- Publication type:
- Article
50
Study designs in paediatric pharmacoepidemiology.
- Published in:
- European Journal of Clinical Pharmacology, 2011, v. 67, p. 67, doi. 10.1007/s00228-010-0930-2
- By:
- Publication type:
- Article